SIDHANT SEHRAWAT: Open Payments
NPI 1770103327 · HOPEWELL JUNCTION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,712 in 122 payments from 31 companies in 2025. Trend: 2023 $1,343 · 2024 $2,498 · 2025 $2,712
Food & beverage: $2,712
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $398 |
| Novo Nordisk Inc | 12 | $286 |
| Exact Sciences Corporation | 8 | $184 |
| GlaxoSmithKline, LLC. | 7 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $155 |
| Novartis Pharmaceuticals Corporation | 7 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $133 |
| AstraZeneca Pharmaceuticals LP | 5 | $117 |
| Sumitomo Pharma America, Inc. | 5 | $116 |
Products named: Wegovy, Cologuard Collection Kit, UBRELVY, XIFAXAN, SHINGRIX, LEQVIO, CAPLYTA, Kerendia.
Industry payments across NY — which companies pay providers there.
